Computer Assisted Drug Designing - Principle and its Application

by Vishwakarma, Pushpendra kumar
State: New
$63.99
VAT included - FREE Shipping
Vishwakarma, Pushpendra kumar Computer Assisted Drug Designing - Principle and its Application
Vishwakarma, Pushpendra kumar - Computer Assisted Drug Designing - Principle and its Application

Do you like this product? Spread the word!

$63.99 incl. VAT
Only 1 items available Only 1 items available
Delivery: between Tuesday, October 5, 2021 and Thursday, October 7, 2021
Sales & Shipping: Dodax

Check other buying options

1 Offer for $74.71

Sold by Dodax EU

$74.71 incl. VAT
State: New
Free Shipping
Delivery: between Tuesday, October 5, 2021 and Thursday, October 7, 2021
View other buying options

Description

Molecular design software is software deals with molecular modeling, that provides special support for developing molecular models de novo. In contrast to the usual molecular modeling programs such as the molecular dynamics and quantum chemistry programs, such software directly supports the aspects related to the construction of molecular models: Molecular graphics interactive molecular drawing and conformational editing building of polymeric molecules, crystals and solvated systems partial charges development geometry optimization support for the different aspects of Force Field development

Contributors

Author:
Vishwakarma, Pushpendra kumar
Gupta, Vikash
Maharaj, Leela

Further information

Biography Artist:
Pushpendra Kumar Vishwakarma have done B.Pharma from oriental college of pharmacy Bhopal, MP ,INDIA .He has been selected as Top 100 Educators of 2011 by Cambridge, UK
Language:
English
Number of Pages:
116
Media Type:
Softcover
Publisher:
LAP Lambert Academic Publishing

Master Data

Product Type:
Paperback book
Package Dimensions:
0.218 x 0.148 x 0.012 m; 0.2 kg
GTIN:
09783848410255
DUIN:
AHUKSOGJO2P
$63.99
We use cookies on our website to make our services more efficient and more user-friendly. Therefore please select "Accept cookies"! Please read our Privacy Policy for further information.